The true cost of bone marrow transplantation

Frederick M. Weeks, Gary C. Yee, Alison A. Bartfield, John R. Wingard

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

Bone marrow transplantation is an example of a highly technical therapy that offers hope to patients with bone marrow failure or various malignancies. Bone marrow transplantation is much more costly 'up-front' but perhaps not more costly long-term than alternative therapies. Although economic analyses appear relatively simple, interpretation and use can be problematic. Several economic analyses have identified complications that occur frequently and affect the reported cost-effectiveness of high-dose chemotherapy. Efforts to reduce the cost of bone marrow transplantation have focused on new strategies to more affectively control these complications. The introduction of new technologies to speed engraftment, to improve patient selection methods, and the shifting of care to outpatient settings all have resulted in significant reductions in duration of hospital stay, treatment- related mortality, and costs. More studies of long-term outcomes are needed for transplant and nontransplant treatment options to guide present and future applications of this treatment option.

Original languageEnglish (US)
Pages (from-to)101-112
Number of pages12
JournalAmerican Journal of the Medical Sciences
Volume314
Issue number2
DOIs
StatePublished - Aug 1997

Keywords

  • Bone marrow transplantation
  • Cost
  • Cost-effectiveness
  • High-dose chemotherapy

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The true cost of bone marrow transplantation'. Together they form a unique fingerprint.

  • Cite this